Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
European Geriatric Medicine|November 19, 2021
Sex-related pharmacokinetic differences with agingFelix Stader, Catia Marzolini
Clinical Pharmacology and Therapeutics|February 24, 2021
Physiologically-Based Pharmacokinetic Modeling to Support the Clinical Management of Drug-Drug Interactions With BictegravirFelix Stader, Manuel Battegay, Catia Marzolini
Clinical Pharmacology and Therapeutics|September 8, 2021
Physiologically Based Pharmacokinetic Modelling to Investigate the Impact of the Cytokine Storm on CYP3A Drug Pharmacokinetics in COVID-19 PatientsFelix Stader, Manuel Battegay, Parham Sendi, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 20, 2019
A Comprehensive Framework for Physiologically-Based Pharmacokinetic Modeling in MatlabFelix Stader, Melissa A Penny, Marco Siccardi, et al.
Open Forum Infectious Diseases|April 10, 2024
Drug Exposure of Long-Acting Cabotegravir and Rilpivirine in Older People With Human Immunodeficiency Virus: A Pharmacokinetic Modeling StudySara Bettonte, Mattia Berton, Felix Stader, et al.
Open Forum Infectious Diseases|October 23, 2024
Ideal Time to Conduct a Pharmacokinetic Investigation After Delivery to Fully Capture the Effect of Pregnancy on Drug ExposureMattia Berton, Felix Stader, Sara Bettonte, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 2, 2024
Development of a physiologically-based pharmacokinetic model to simulate the pharmacokinetics of intramuscular antiretroviral drugsSara Bettonte, Mattia Berton, Manuel Battegay, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 15, 2022
Management of Drug-Drug Interactions Between Long-Acting Cabotegravir and Rilpivirine and Comedications With Inducing Properties: A Modeling StudySara Bettonte, Mattia Berton, Felix Stader, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 3, 2024
Effect of Obesity on the Exposure of Long-acting Cabotegravir and Rilpivirine: A Modeling StudySara Bettonte, Mattia Berton, Felix Stader, et al.
Pageof 5